Xylem Inc Stock EBITDA

XYL Stock

USD 127.44 2.08 1.66%

Xylem Inc fundamentals help investors to digest information that contributes to Xylem's financial success or failures. It also enables traders to predict the movement of Xylem Stock. The fundamental analysis module provides a way to measure Xylem's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Xylem stock.

		Last Reported	Projected for Next Year
	EBITDA	1.3 B	791.4 M

The value of EBITDA is estimated to slide to about 791.4 M.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Xylem Inc Company EBITDA Analysis

Xylem's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current Xylem EBITDA

1.29 B

Most of Xylem's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Xylem Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Xylem EBITDA Driver Correlations

Understanding the fundamental principles of building solid financial models for Xylem is extremely important. It helps to project a fair market value of Xylem Stock properly, considering its historical fundamentals such as EBITDA. Since Xylem's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Xylem's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Xylem's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Accounts Payable	Net Receivables	Good Will	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Property Plant Equipment	Net Tangible Assets	Current Deferred Revenue	Retained Earnings	Long Term Debt	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Treasury Stock	Short Term Debt	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.96	0.44	0.76	0.79	0.99	0.67	0.71	0.97	-0.34	0.68	0.01	-0.52	0.69	0.62	0.58	0.85	0.43	-0.7	0.02	-0.02	0.56	0.8	0.65	0.8
Total Stockholder Equity	0.96		0.25	0.63	0.72	0.98	0.45	0.57	0.92	-0.18	0.47	0.21	-0.37	0.52	0.4	0.36	0.75	0.25	-0.52	-0.1	-0.14	0.41	0.83	0.58	0.87
Net Debt	0.44	0.25		0.61	0.58	0.42	0.76	0.36	0.6	-0.56	0.85	-0.78	-0.59	0.57	0.74	0.73	0.51	0.85	-0.57	0.46	0.44	0.16	0.27	0.03	0.23
Accounts Payable	0.76	0.63	0.61		0.95	0.7	0.87	0.86	0.75	-0.36	0.88	-0.22	-0.78	0.94	0.79	0.76	0.97	0.57	-0.83	0.15	0.12	0.62	0.77	0.65	0.66
Net Receivables	0.79	0.72	0.58	0.95		0.77	0.78	0.8	0.79	-0.39	0.81	-0.09	-0.68	0.82	0.63	0.59	0.93	0.47	-0.69	0.08	0.06	0.47	0.87	0.55	0.81
Good Will	0.99	0.98	0.42	0.7	0.77		0.57	0.6	0.98	-0.27	0.6	0.03	-0.46	0.59	0.53	0.49	0.79	0.4	-0.6	0.01	-0.03	0.44	0.81	0.56	0.84
Total Liab	0.67	0.45	0.76	0.87	0.78	0.57		0.87	0.69	-0.58	0.97	-0.46	-0.73	0.91	0.92	0.91	0.85	0.71	-0.85	0.3	0.26	0.73	0.56	0.6	0.41
Total Current Assets	0.71	0.57	0.36	0.86	0.8	0.6	0.87		0.62	-0.47	0.77	0.01	-0.61	0.88	0.71	0.69	0.9	0.35	-0.79	0.03	-0.01	0.86	0.71	0.84	0.56
Intangible Assets	0.97	0.92	0.6	0.75	0.79	0.98	0.69	0.62		-0.35	0.73	-0.17	-0.54	0.67	0.66	0.63	0.81	0.56	-0.68	0.13	0.09	0.46	0.76	0.52	0.77
Common Stock	-0.34	-0.18	-0.56	-0.36	-0.39	-0.27	-0.58	-0.47	-0.35		-0.58	0.11	0.32	-0.39	-0.31	-0.31	-0.35	-0.27	0.41	-0.14	-0.12	-0.19	-0.13	-0.15	-0.09
Property Plant Equipment	0.68	0.47	0.85	0.88	0.81	0.6	0.97	0.77	0.73	-0.58		-0.53	-0.78	0.88	0.91	0.9	0.82	0.79	-0.83	0.35	0.32	0.59	0.52	0.48	0.41
Net Tangible Assets	0.01	0.21	-0.78	-0.22	-0.09	0.03	-0.46	0.01	-0.17	0.11	-0.53		0.39	-0.26	-0.63	-0.66	-0.09	-0.78	0.3	-0.59	-0.59	-0.06	0.17	0.21	0.24
Current Deferred Revenue	-0.52	-0.37	-0.59	-0.78	-0.68	-0.46	-0.73	-0.61	-0.54	0.32	-0.78	0.39		-0.8	-0.74	-0.74	-0.71	-0.48	0.76	-0.47	-0.47	-0.46	-0.38	-0.37	-0.28
Retained Earnings	0.69	0.52	0.57	0.94	0.82	0.59	0.91	0.88	0.67	-0.39	0.88	-0.26	-0.8		0.84	0.83	0.94	0.6	-0.95	0.13	0.1	0.73	0.6	0.67	0.46
Long Term Debt	0.62	0.4	0.74	0.79	0.63	0.53	0.92	0.71	0.66	-0.31	0.91	-0.63	-0.74	0.84		1.0	0.76	0.81	-0.84	0.42	0.39	0.72	0.43	0.58	0.3
Long Term Debt Total	0.58	0.36	0.73	0.76	0.59	0.49	0.91	0.69	0.63	-0.31	0.9	-0.66	-0.74	0.83	1.0		0.73	0.82	-0.83	0.43	0.41	0.72	0.38	0.56	0.24
Capital Surpluse	0.85	0.75	0.51	0.97	0.93	0.79	0.85	0.9	0.81	-0.35	0.82	-0.09	-0.71	0.94	0.76	0.73		0.5	-0.88	0.07	0.03	0.68	0.82	0.74	0.73
Deferred Long Term Liab	0.43	0.25	0.85	0.57	0.47	0.4	0.71	0.35	0.56	-0.27	0.79	-0.78	-0.48	0.6	0.81	0.82	0.5		-0.59	0.26	0.24	0.31	0.21	0.19	0.14
Treasury Stock	-0.7	-0.52	-0.57	-0.83	-0.69	-0.6	-0.85	-0.79	-0.68	0.41	-0.83	0.3	0.76	-0.95	-0.84	-0.83	-0.88	-0.59		-0.19	-0.15	-0.69	-0.47	-0.63	-0.35
Short Term Debt	0.02	-0.1	0.46	0.15	0.08	0.01	0.3	0.03	0.13	-0.14	0.35	-0.59	-0.47	0.13	0.42	0.43	0.07	0.26	-0.19		1.0	0.04	-0.1	-0.1	-0.11
Short Long Term Debt	-0.02	-0.14	0.44	0.12	0.06	-0.03	0.26	-0.01	0.09	-0.12	0.32	-0.59	-0.47	0.1	0.39	0.41	0.03	0.24	-0.15	1.0		0.02	-0.14	-0.13	-0.15
Cash And Equivalents	0.56	0.41	0.16	0.62	0.47	0.44	0.73	0.86	0.46	-0.19	0.59	-0.06	-0.46	0.73	0.72	0.72	0.68	0.31	-0.69	0.04	0.02		0.47	0.87	0.29
Net Invested Capital	0.8	0.83	0.27	0.77	0.87	0.81	0.56	0.71	0.76	-0.13	0.52	0.17	-0.38	0.6	0.43	0.38	0.82	0.21	-0.47	-0.1	-0.14	0.47		0.63	0.97
Net Working Capital	0.65	0.58	0.03	0.65	0.55	0.56	0.6	0.84	0.52	-0.15	0.48	0.21	-0.37	0.67	0.58	0.56	0.74	0.19	-0.63	-0.1	-0.13	0.87	0.63		0.51
Capital Stock	0.8	0.87	0.23	0.66	0.81	0.84	0.41	0.56	0.77	-0.09	0.41	0.24	-0.28	0.46	0.3	0.24	0.73	0.14	-0.35	-0.11	-0.15	0.29	0.97	0.51

Click cells to compare fundamentals

Xylem EBITDA Historical Pattern

Today, most investors in Xylem Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Xylem's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's ebitda growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Xylem ebitda as a starting point in their analysis.

Xylem EBITDA

Timeline

In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.

Competition

Predict Xylem

Ebitda Over Time

Xylem Ebitda

Ebitda

791.41 Million

At this time, Xylem's EBITDA is quite stable compared to the past year.

According to the company disclosure, Xylem Inc reported earnings before interest,tax, depreciation and amortization of 1.29 B. This is 121.09% higher than that of the Machinery sector and significantly higher than that of the Industrials industry. The ebitda for all United States stocks is 66.96% higher than that of the company.

Xylem EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Xylem's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Xylem could also be used in its relative valuation, which is a method of valuing Xylem by comparing valuation metrics of similar companies.

Xylem is currently under evaluation in ebitda category among its peers.

Xylem ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Xylem's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Xylem's managers, analysts, and investors.

Environmental

Governance

Social

Xylem Institutional Holders

Institutional Holdings refers to the ownership stake in Xylem that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Xylem's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Xylem's value.

		Shares
Amvescap Plc.	2024-06-30	3.4 M
Dz Bank Ag Deutsche Zentral-genossenschaftsbank Frankfurt Am Main	2024-06-30	3.3 M
Swedbank Ab	2024-09-30	3 M
Bank Of America Corp	2024-06-30	2.7 M
Norges Bank	2024-06-30	2.5 M
American Century Companies Inc	2024-09-30	2.3 M
Northern Trust Corp	2024-09-30	2.3 M
Legal & General Group Plc	2024-06-30	2.3 M
Goldman Sachs Group Inc	2024-06-30	2.3 M
Vanguard Group Inc	2024-09-30	28.3 M
Blackrock Inc	2024-06-30	23.4 M

Xylem Fundamentals

	Return On Equity	0.0808
	Return On Asset	0.0443
	Profit Margin	0.1 %
	Operating Margin	0.14 %
	Current Valuation	31.57 B
	Shares Outstanding	242.94 M
	Shares Owned By Insiders	0.64 %
	Shares Owned By Institutions	93.74 %
	Number Of Shares Shorted	2.49 M
	Price To Earning	64.49 X
	Price To Book	2.88 X
	Price To Sales	3.62 X
	Revenue	7.36 B
	Gross Profit	2.09 B
	EBITDA	1.29 B
	Net Income	609 M
	Cash And Equivalents	944 M
	Cash Per Share	6.58 X
	Total Debt	2.66 B
	Debt To Equity	0.75 %
	Current Ratio	1.65 X
	Book Value Per Share	43.59 X
	Cash Flow From Operations	837 M
	Short Ratio	2.50 X
	Earnings Per Share	3.49 X
	Price To Earnings To Growth	2.36 X
	Target Price	147.95
	Number Of Employees	23 K
	Beta	1.05
	Market Capitalization	30.46 B
	Total Asset	16.11 B
	Retained Earnings	2.6 B
	Working Capital	1.68 B
	Current Asset	2 B
	Current Liabilities	823 M
	Annual Yield	0.01 %
	Five Year Return	1.15 %
	Net Asset	16.11 B
	Last Dividend Paid	1.41

About Xylem Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Xylem Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Xylem using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Xylem Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Xylem Inc is a strong investment it is important to analyze Xylem's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Xylem's future performance. For an informed investment choice regarding Xylem Stock, refer to the following important reports:

How To Invest In Xylem

Details

Is Xylem Stock a good investment?

Details

What is Xylem's Net Worth?

Details

Largest Specialty Industrial Machinery Companies

View

Largest Industrials Companies

View

Check out Xylem Piotroski F Score and Xylem Altman Z Score analysis.

You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Is Industrial Machinery & Supplies & Components space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xylem. If investors know Xylem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xylem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.413

Dividend Share

1.41

Earnings Share

3.49

Revenue Per Share

34.788

Quarterly Revenue Growth

0.013

The market value of Xylem Inc is measured differently than its book value, which is the value of Xylem that is recorded on the company's balance sheet. Investors also form their own opinion of Xylem's value that differs from its market value or its book value, called intrinsic value, which is Xylem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xylem's market value can be influenced by many factors that don't directly affect Xylem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Xylem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Xylem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xylem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Xylem Inc Stock EBITDA

Xylem Inc Company EBITDA Analysis

EBITDA

Revenue

-

Basic Expenses

Current Xylem EBITDA

Xylem EBITDA Driver Correlations

Xylem EBITDA Historical Pattern

Xylem Ebitda

Ebitda

791.41 Million

Xylem EBITDA Peer Comparison

Xylem ESG Sustainability

Xylem Institutional Holders

Xylem Fundamentals

About Xylem Fundamental Analysis

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY